<DOC>
	<DOCNO>NCT02350985</DOCNO>
	<brief_summary>The present study aim compare effectivity propranolol effectivity venlafaxine escalate dose subject vestibular migraine ( VM ) period 12 week . The study population consist subject diagnose definite VM accord criterion B치r치ny Society Migraine Classification Subcommittee International Headache Society ( IHS ) . Effectivity therapy measure Dizziness Handicap Inventory ( DHI ) , number vertiginous attack last month visual analogue scale ( VAS ) report dizziness relate Quality Life ( QOL ) . Beck Anxiety Inventory ( BAI ) Beck Depression Inventory ( BDI ) also use determine psychiatric improvement play role response therapy venlafaxine treatment arm .</brief_summary>
	<brief_title>Comparison Propranolol Venlafaxine Treatment Vestibular Migraine</brief_title>
	<detailed_description>Vestibular migraine ( VM ) condition episodic vertigo link migrainous symptom describe Nueuhauser et al . 2001 . Some subject benefit behavior diet modification control symptom . Anti-migrainous medication prophylactic aim give subject benefit life-style improvement . However , absence sufficient evidence treatment VM . In study investigator aim evaluated effectiveness prophylactic treatment venlafaxine compare propranolol VM . The investigator also aim investigate effectiveness venlafaxine link improvement psychiatric condition . All subject suspect VM refer M.S . ( Department Otolaryngology ) H.A . ( Department Neurology ) order ensure subject fill criterion VM vestibular disorder . All subject underwent detailed neurologic , neurotologic examination , audiometric investigation , videonystagmography ( VNG ) bithermal caloric test order exclude additional vestibular neurologic disease . Subjects were18 year old history ( least 2 month ) definite VM accord criterion B치r치ny Society Migraine Classification Subcommittee International Headache Society ( IHS ) eligible study . After subject fill eligibility criterion study respond lifestyle dietary modification enrol study . Subjects enrol study fill inclusion exclusion criterion write informed consent obtain subject . Subjects randomize use seal envelop method A.K . ( Department Otolaryngology ) . Before start intervention protocol Dizziness Handicap Inventory ( DHI ) , number vertiginous attack last month visual analogue scale ( VAS ) report dizziness relate Quality Life ( QOL ) , Beck Anxiety Inventory ( BAI ) Beck Depression Inventory ( BDI ) obtain subject T.Y . ( Department Otolaryngology ) . Subjects give propranolol venlafaxine treatment accord randomization balance allocation ( 1:1 ) . The study unblinded study investigational propranolol pay government health insurance . However , venlafaxine pay migraine therapy government health insurance venlafaxine provide Institution Research Funding System . The intervention protocol carry T.Y . supervision H.A M.S.. Propranolol give flexible dose 40 mg 160 mg escalate fashion start 40 mg PO AM one week follow 40 mg AM 40 mg PM total dose 160 mg daily . Venlafaxine treatment follow : 37.5 mg qhs two week follow 75 mg qhs escalate dose 2 week period 150 mg daily . All participant ask self-titrate medication case inform researcher . Subjects see clinic biweekly first month order evaluate adverse effect make sure participant sufficient dosage . The effective duration treatment consider 3 month participant ask continue use medication one month order evaluate change baseline 3rd month term number vertiginous attack last month . All participant assess clinic month 1 , 3 4 . Change baseline DHI , VAS , BAI BDI score 4th month . Adverse effect , reason exclude subject study , reason subject refuse continue study reason subject could follow protocol record clinic visit obtain phone home . The analysis primary endpoint perform follow intention-to-treat ( ITT ) method . Missing data handle multiple imputation method .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>vestibular migraine respond lifestyle dietary modification know allergic reaction venlafaxine propranolol care psychiatrist pregnancy intention become pregnant presence significant illness medical condition cancer , liver kidney failure certain medical condition possible adverse effect propranolol venlafaxine following : AV block bradyarrhythmia ; astma COPD ; diabetes mellitus .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Migraine</keyword>
	<keyword>Migrainous Vertigo</keyword>
	<keyword>Headache Disorders</keyword>
	<keyword>Central Nervous System Origin Vertigo</keyword>
	<keyword>Paroxysmal Vertigo</keyword>
	<keyword>Adrenergic beta-Antagonist</keyword>
	<keyword>Vasodilator Agent</keyword>
	<keyword>Anti Arrhythmia Agent</keyword>
	<keyword>Serotonin Uptake Inhibitor</keyword>
	<keyword>Antidepressive Agent</keyword>
	<keyword>Propranolol</keyword>
	<keyword>Venlafaxine</keyword>
</DOC>